EN
Enovis Corporation
ENOV · NYSE
$17.95 -1.51% (-$0.28)
1M -27.49%
Market Cap $1.03B
P/E Ratio -
Div. Yield -
ROE 68.17%
Bulios Fair Price
$20.46
14.0% upside
Trenutna cena
$17.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ENOV trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
90 /100
Cheap P/S 0.45x
P/B 0.70x
P/FCF 16.23x
Growth
61 /100
Stable Rev. growth 12.88%
Book val. growth 24.40%
EPS growth N/A
Profitability
32 /100
Weak Gross margin 57.43%
Net margin 47.97%
Op. margin 4.14%
Quality
13 /100
Poor ROIC 3.04%
ROE 68.17%
ROA 29.25%
Debt
48 /100
Moderate Debt/Equity 0.93x
Current ratio 1.98x
Int. coverage -18.23x
Stability
39 /100
Moderate Beta 1.43x
Rev. volatility 9.05%
EPS volatility 1,310.45%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ENOV
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Damien McDonald
Employees
7,802
Headquarters
Wilmington
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report